Half-year report · HY

Period2025-06-01 → 2025-11-30
Filed2026-01-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
MetricValuePeriodScopeSource row
Revenue¥537.2bn2025-06-01 → 2025-11-30Cons.Net sales
Revenue¥1.01T2024-06-01 → 2025-05-31Cons.Net sales (5-year summary)
Revenue¥505.9bn2024-06-01 → 2024-11-30Cons.Net sales
Operating income¥20.7bn2025-06-01 → 2025-11-30Cons.Operating income
Operating income¥20.3bn2024-06-01 → 2024-11-30Cons.Operating income
Ordinary income¥21.9bn2025-06-01 → 2025-11-30Cons.Ordinary income
Ordinary income¥43.2bn2024-06-01 → 2025-05-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥21.8bn2024-06-01 → 2024-11-30Cons.Ordinary income
Profit before tax¥21.7bn2025-06-01 → 2025-11-30Cons.Income before income taxes
Profit before tax¥21.4bn2024-06-01 → 2024-11-30Cons.Income before income taxes
Net income (owners)¥14.6bn2025-06-01 → 2025-11-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥31.0bn2024-06-01 → 2025-05-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥14.4bn2024-06-01 → 2024-11-30Cons.Profit loss attributable to owners of parent
Net income¥14.6bn2025-06-01 → 2025-11-30Cons.Profit loss
Net income¥14.4bn2024-06-01 → 2024-11-30Cons.Profit loss
Total assets¥542.7bnat 2025-11-30Cons.Assets
Total assets¥524.8bnat 2025-05-31Cons.Assets
Total assets¥486.6bnat 2024-11-30Cons.Total assets (5-year summary)
Total liabilities¥273.6bnat 2025-11-30Cons.Liabilities
Total liabilities¥267.3bnat 2025-05-31Cons.Liabilities
Net assets / equity¥269.1bnat 2025-11-30Cons.Net assets
Net assets / equity¥257.5bnat 2025-05-31Cons.Net assets
Net assets / equity¥243.5bnat 2024-11-30Cons.Net assets (5-year summary)
Cash and deposits¥43.2bnat 2025-11-30Cons.Cash and deposits
Cash and deposits¥57.0bnat 2025-05-31Cons.Cash and deposits
Cash & equivalents¥43.2bnat 2025-11-30Cons.Cash and cash equivalents
Cash & equivalents¥57.0bnat 2025-05-31Cons.Cash and cash equivalents
Cash & equivalents¥39.1bnat 2024-11-30Cons.Cash and cash equivalents
Cash & equivalents¥52.3bnat 2024-05-31vCons.Cash and cash equivalents
Operating cash flow¥22.1bn2025-06-01 → 2025-11-30Cons.Net cash provided by used in operating activities
Operating cash flow¥52.5bn2024-06-01 → 2025-05-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥15.1bn2024-06-01 → 2024-11-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥29.0bn2025-06-01 → 2025-11-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥55.4bn2024-06-01 → 2025-05-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥22.5bn2024-06-01 → 2024-11-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥7.0bn2025-06-01 → 2025-11-30Cons.Net cash provided by used in financing activities
Financing cash flow¥7.7bn2024-06-01 → 2025-05-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥5.7bn2024-06-01 → 2024-11-30Cons.Net cash provided by used in financing activities
EPS (basic)¥184.832025-06-01 → 2025-11-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥390.862024-06-01 → 2025-05-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥182.052024-06-01 → 2024-11-30Cons.Basic earnings loss per share (5-year summary)
Equity ratio49.6%at 2025-11-30Cons.Equity to asset ratio (5-year summary)
Equity ratio49.1%at 2025-05-31Cons.Equity to asset ratio (5-year summary)
Equity ratio50.0%at 2024-11-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

All source rows · 428
ItemContextValueUnit
Description issued shares voting rightsInterimInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember-
Description issued shares voting rightsInterimInstant_SharesWithRestrictedVotingRightsOtherMember-
Description issued shares voting rightsInterimInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember-
Description issued shares voting rightsInterimInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember-
Description issued shares voting rightsInterimInstant_OrdinarySharesSharesLessThanOneUnitMember
Original text (Japanese)1単元(100株)未満株式
Treasury shares etc (text)FilingDateInstantText · Plus
Name of shareholder treasury shares etcInterimInstant_Row1Member
Original text (Japanese)株式会社コスモス薬品
Address of shareholder treasury shares etcInterimInstant_Row1Member
Original text (Japanese)福岡市博多区博多駅東二丁目10番1号
Information about officers (text)FilingDateInstantText · Plus
Regulations in accordance with which consolidated financial statements have been prepared financial informationInterimDurationText · Plus
Type1 semi annual consolidated financial statements financial informationInterimDurationText · Plus
Note on independent audit financial informationInterimDurationText · Plus
Type1 semi annual consolidated balance sheet (text)InterimDurationText · Plus
Type1 semi annual consolidated statement of income (text)InterimDurationText · Plus
Type1 semi annual consolidated statement of comprehensive income (text)InterimDurationText · Plus
Type1 semi annual consolidated statement of cash flows (text)InterimDurationText · Plus
Notes accounting treatments specific to semi annual financial statements type1 semi annual consolidated financial statements (text)InterimDurationText · Plus
Major components of selling general and administrative expenses (text)InterimDurationText · Plus
Reconciliation of ending balance of cash and cash equivalents with account balances per balance sheet (text)InterimDurationText · Plus
Notes regarding dividend (text)Prior1InterimDurationText · Plus
Notes regarding dividend (text)InterimDurationText · Plus
Notes segment information etc type1 semi annual consolidated financial statements (text)InterimDurationText · Plus
Description of fact that companys business comprises single segmentPrior1InterimDuration
Original text (Japanese)当社グループは医薬品・化粧品等の小売業という単一のセグメントであるため、記載を省略しております。
Description of fact that companys business comprises single segmentInterimDuration
Original text (Japanese)当社グループは医薬品・化粧品等の小売業という単一のセグメントであるため、記載を省略しております。
Notes revenue recognition semi annual consolidated financial statements (text)InterimDurationText · Plus
Notes per share information semi annual consolidated financial statements (text)InterimDurationText · Plus
Other information consolidated financial statements etc (text)InterimDurationText · Plus
Information about company which provides guarantee to reporting company (text)FilingDateInstantText · Plus

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2025-05-31pass
balance sheet identityconsolidated 2025-11-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2025-05-31pass
statement vs summary · net assetsconsolidated 2025-11-30pass
statement vs summary · net income attributable to parentconsolidated 2024-06-01/2024-11-30pass
statement vs summary · net income attributable to parentconsolidated 2025-06-01/2025-11-30pass
statement vs summary · operating cash flowconsolidated 2024-06-01/2024-11-30pass
statement vs summary · operating cash flowconsolidated 2025-06-01/2025-11-30pass
statement vs summary · revenueconsolidated 2024-06-01/2024-11-30pass
statement vs summary · revenueconsolidated 2025-06-01/2025-11-30pass
statement vs summary · total assetsconsolidated 2025-05-31pass
statement vs summary · total assetsconsolidated 2025-11-30pass